tirzepatide-niacinamide tirzepatide niacinamide injection dosage Physician-led weight loss program with GLP-1 medication in Birmingham Compounded Tirzepatide - Medical Weight

First: What Is a GLP-1 Medication

This compounds over weeks

This is especially risky if you are also taking other medications for blood sugar management

10.1111/dom.14496

They should be counseled to contact their healthcare provider if they develop symptoms potentially indicating lactic acidosis, including unusual muscle pain, difficulty breathing, severe fatigue, dizziness, or abdominal discomfort

Keywords: tirzepatide, postmarketing surveillance, drug safety, adverse events Introduction Tirzepatide, a novel dual agonist targeting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors marketed as Zepbound by its manufacturer Eli Lilly and Company, has shown significant efficacy in managing type 2 diabetes mellitus (T2DM) and obesity, as demonstrated in key clinical trials such as SURPASS [1] and SURMOUNT [2]